Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1998-02-23
1999-01-05
Huff, Sheela
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303895, 4351722, 435339, 435340, 4241501, 4241641, 4242341, A61K 31395
Patent
active
058564470
ABSTRACT:
The present invention provides a vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi.
The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies, hybridomas and antigens.
REFERENCES:
patent: 5178859 (1993-01-01), Simon et al.
patent: 5434077 (1995-07-01), Simon et al.
Eichmann Klaus
Kramer Michael
Reinhard Wallich
Schaible Ulrich E.
Simon Markus M.
Huff Sheela
Max-Planck-Gesellschaft zur Forderung der Wissenschaften
Reeves Julie E.
LandOfFree
Hybridomas producing antibodies specific for lyme disease antige does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybridomas producing antibodies specific for lyme disease antige, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybridomas producing antibodies specific for lyme disease antige will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863449